ISB News

Best Ever Valerie Logan Lunch: $120K Raised

The 5th Annual Valerie Logan Luncheon, which took place on Nov. 29, was our most successful yet, having raised $120,000 for ISB’s education programs. There were a few tear-jerker moments, including when Lee Hood interviewed some students: Sara Michelassi, who will graduate next spring with her high school diploma AND her AA in science from North Seattle College, said that she’s always dreamed of working in a lab, “but I doubted if that dream was achievable, because I thought I needed connections or lots of money in order to land such a competitive internship. But ISB showed me that everyone deserves the opportunity to pursue their dreams, no matter their status.” The double whammy was when Sara expressed her gratitude for having a paid internship, which helped to support her family.

Thank you to our sponsors!

Presenting Sponsor: Sabey Corporation
Platinum Sponsor: Aron M. Thompson
Gold Sponsors: The Boeing Co., Muckleshoot Charity Fund, Kidder Mathews, Douglas Howe & Robin DuBrin, and Providence Health & Services
Silver Sponsors: Arthur J. Gallagher & Co., Tulalip Tribes Charitable Fund, and Kilroy Realty

Read emcee Patti Payne’s followup column in the Puget Sound Business Journal.

Recent Articles

  • Timing is Everything: ISB Study Finds Link Between Bowel Movement Frequency and Overall Health

    Everybody poops, but not every day. An ISB-led research team examined the clinical, lifestyle, and multi-omic data of more than 1,400 healthy adults. How often people poop, they found, can have a large influence on one’s physiology and health.

  • Wei Wei, PhD

    Dr. Wei Wei Promoted to Associate Professor

    Wei Wei, PhD – an accomplished cancer researcher with expertise in biotechnology and cancer systems biology – has been promoted to ISB associate professor. The Wei Lab focuses on understanding how cancer cells adapt to therapeutic treatment to foster therapy resistance by coordinating their internal molecular machinery and how these adaptive changes evolve within diverse tumors influenced by the tumor microenvironment. 

  • Drs. Nitin Baliga and James Park

    How Glioblastoma Resists Treatment – and Ways to Prevent It

    Glioblastoma is one of the deadliest and most aggressive forms of primary brain cancer in adults and is known for its ability to resist treatment and to recur. ISB researchers have made breakthrough discoveries in understanding the mechanisms behind acquired resistance, focusing on a rare and stubborn group of cells within tumors called glioma stem-like cells.